IP Library › Granted Patent US 9,220,267
Granted Patent B2
US 9,220,267 · App. 14/507,431 · Granted Dec 29, 2015

Methods of use comprising a biocidal polyamine

Inventors: Dustin Williams (Bountiful, UT); Ryan Looper (Salt Lake City, UT); Sujeevini Jeyapalina (Salt Lake City, UT); Travis Haussener (Midvale, UT); Paul R. Sebahar (Sandy, UT); Hari Kanna Reddy (Salt Lake City, UT)
Assignees: Curza Global, LLC; University of Utah Research Foundation
A01N43/84A01N33/00A01N33/04A01N33/10A01N37/06A01N37/18A01N37/30A01N43/10A01N43/30A01N43/40A01N47/12A61K31/135A61K31/137C07C211/09C07C211/11C07C211/14C07C211/27C07C217/54C07C217/58C07C225/12C07C233/78C07C237/34C07C271/20C07D295/135C07D317/58C07D333/20
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,220,267
App. No.
14/507,431
Granted
Dec 29, 2015
Kind
B2
Abstract

Compounds, compositions, and methods comprising a polyamine compound are described, which may be used to kill, disperse, treat, reduce biofilms, and/or inhibit or substantially prevent biofilm formation. In certain aspects, the present invention relates to compounds, compositions, and methods comprising polyamine compounds that have antimicrobial or dispersing activity against a variety of bacterial strains capable of forming biofilms.

Claims (41)

1. A method for dispersing or killing a biofilm, the method comprising a step of contacting the biofilm with an anti-biofilm composition, thereby dispersing or killing the biofilm;

wherein the anti-biofilm composition comprises a biocidal polyamine compound selected from the group consisting of:

and a salt thereof;

wherein:

each R a is an independently selected group of the formula:

each R m is a member independently selected from the group consisting of —CR 2a R 2b —, —C(R 2a )═(R 2b )—, —CC—, and —C(R 2a )(R 2b )-L-C(R 2c )(R 2d )—;

each m is an integer independently selected from 1 to 10;

each R 2a , R 2b , R 2c , and R 2d is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, aryl, heteroaryl, arylalkyl, or heteroarylalkyl; alternatively, a pair of R 2 members from the same R a group independently selected from the group consisting of the pair R 2a and R 2b and the pair R 2c and R 2d join to form a member independently selected from the group consisting of spirocycloalkyl, spiroheterocycyl, and oxo; or, alternatively, an R 2a and an R 2c from the same R a group join to form a ring independently selected from the group consisting of cycloalkyl and heterocycyl;

each L is a member independently selected from the group consisting of a bond, —O—, —C(O)O—, —NR 4 —, —NR 4 C(O)—, and —C(O)NR 4 —;

each R 3 is a member independently selected from the group consisting of —Z 1 —Y 1 —R 4 and —Z—Y 1 —Y 2 —R 4 ;

each R 4 is a member independently selected from the group consisting of hydrogen, alkyl, fluoroalkyl, alkenyl, alkynyl, arylalkyl, and heteroarylalkyl; or, alternatively, for a —N(R 4 ) 2 group, one of the two R 4 in the group is a member selected from the group consisting of —(CO)OR 6a —, (CO)N(R 6a )(R 6b ), and —C(NR 6a )N(R 6b )(R 6c );

each Y 1 and Y 2 is an independently selected group of the formula:

each Z 1 and Z 2 is an independently selected NR 4 ; and

each R 6a , R 6b , and R 6c is a member independently selected from the group consisting of hydrogen, alkyl, and fluoroalkyl; or, alternatively, two R 6 members R 6a and R 6b or R 6a and R 6c join to form an additional heterocycyl ring;

wherein the biocidal polyamine compound comprises at least four primary or secondary amino groups.

2. The method of claim 1 , wherein the biocidal polyamine compound comprises at least six primary or secondary amino groups.

3. The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of:

and a salt thereof.

4. The method of claim 3 , wherein m is 1 or 2; and wherein R m is —CH 2 —.

5. The method of claim 4 , wherein the biocidal polyamine salt is a hydrochloride.

6. The method of claim 4 , wherein R 4 is selected from the group consisting of hydrogen and alkyl.

7. The method of claim 6 , wherein R 4 is isobutyl.

8. The method of claim 4 , wherein the biocidal polyamine compound is selected from the group consisting of

and a salt thereof.

9. The method of claim 1 , wherein the biocidal polyamine compound is selected from the group consisting of:

and a salt thereof.

10. The method of claim 9 , wherein m is 1 or 2; and wherein R m is —CH 2 —.

11. The method of claim 10 , wherein the biocidal polyamine salt is a hydrochloride.

12. The method of claim 10 , wherein R 4 is selected from the group consisting of hydrogen and alkyl.

13. The method of claim 12 , wherein R 4 is isobutyl.

14. The method of claim 10 , wherein the biocidal polyamine compound is selected from the group consisting of

and a salt thereof.

15. The method of claim 1 , wherein the step of treating the biofilm with an anti-biofilm composition disperses the biofilm.

16. The method of claim 1 , wherein the biofilm comprises an antibiotic-resistant bacterial species.

17. The method of claim 1 , wherein the method comprises a step of treating a contact lens with the anti-biofilm composition.

18. The method of claim 1 , wherein the method comprises a step of treating a pipe with the anti-biofilm composition.

19. The method of claim 1 , wherein the method comprises a step of treating a heating or cooling tower with the anti-biofilm composition.

20. The method of claim 1 , wherein the method comprises a step of coating an object with the anti-biofilm composition.

21. The method of claim 1 , wherein the anti-biofilm composition is a paint.

22. The method of claim 1 , wherein the method comprises a step of treating a patient with a biofilm-related disorder.

23. A method for inhibiting formation of a biofilm, the method comprising a step of treating planktonic bacteria with an anti-biofilm composition of claim 1 , thereby inhibiting incorporation of the planktonic bacteria into the biofilm.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2015
From: LOOPER, RYAN; WILLIAMS, DUSTIN; JEYAPALINA, SUJEEVINI; HAUSSENER, TRAVIS; SEBAHAR, PAUL R.; REDDY, HARI KANNA
To: CURZA GLOBAL, LLC; THE UNIVERSITY OF UTAH
Reel/Frame 034829/0666 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 28, 2015
From: THE UNIVERSITY OF UTAH
To: UNIVERSITY OF UTAH RESEARCH FOUNDATION
Reel/Frame 034829/0809 →
Continuity (6)
Continuation 14076143 · Nov 8, 2013
Provisional Application 61836555 · Jun 18, 2013
Provisional Application 61834149 · Jun 12, 2013
Provisional Application 61826761 · May 23, 2013
Provisional Application 61826453 · May 22, 2013
Related Publication 20150038705A1 · Feb 5, 2015